Octavius Sturges
Octavius Sturges (1833–1894) was a notable English physician known for his contributions to pediatrics and his work on the diseases of children. He was a prominent figure in the medical community during the late 19th century.
Early Life and Education[edit | edit source]
Octavius Sturges was born in 1833. He pursued his medical education at St George's Hospital, London, where he developed a keen interest in pediatrics. He graduated with a degree in medicine and began his career as a physician.
Medical Career[edit | edit source]
Sturges started his professional career at St George's Hospital, London, where he worked closely with children suffering from various ailments. His dedication to the field of pediatrics led him to publish several influential works on the subject.
Contributions to Pediatrics[edit | edit source]
Sturges is best known for his research and publications on the diseases of children. He made significant advancements in understanding and treating pediatric conditions, which were documented in his numerous medical papers and books. His work laid the foundation for modern pediatric practices and influenced many future physicians.
Publications[edit | edit source]
Among his notable publications are:
- The Natural History and Relations of Pneumonia in Children - A comprehensive study on pneumonia in pediatric patients.
- The Diseases of Children - A seminal work that became a reference for pediatricians.
Legacy[edit | edit source]
Octavius Sturges' contributions to the field of pediatrics have had a lasting impact. His research and publications continue to be referenced by medical professionals and have helped shape the modern understanding of pediatric diseases.
Related Pages[edit | edit source]
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD